BirchBioMed Inc. is a biomedical company focused on the commercialization, clinical evaluation and development of proprietary anti-scarring drugs, autoimmune therapeutics/therapies and novel strategies for transplantation. As a University of British Columbia (UBC) spinoff, BirchBioMed holds the exclusive, worldwide pharmaceutical license for two medical therapeutic technologies from UBC, which the university considers to be significant medical breakthroughs in the treatment of scarring and certain autoimmune diseases.
View Top Employees from BirchBioMed| Website | http://birchbiomed.ca |
| Revenue | $7 million |
| Employees | 1 (1 on RocketReach) |
| Founded | 2015 |
| Address | 130 KINGSCROSS Dr, King City, Ontario L7B 1E6, CA |
| Phone | (866) 350-1993 |
| Industry | Business Services General, Biotechnology, Business Services, Science and Engineering, Therapeutics, Health Care |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54171 Companies, NAICS Code 541714 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies |
Looking for a particular BirchBioMed employee's phone or email?
BirchBioMed Questions
The BirchBioMed annual revenue was $7 million in 2024.
Jonathan Bourne is the Chief Science Officer of BirchBioMed.
1 people are employed at BirchBioMed.
BirchBioMed is based in King City, Ontario.
The NAICS codes for BirchBioMed are [54171, 541714, 5417, 54, 541].
The SIC codes for BirchBioMed are [87, 873].
Top BirchBioMed Employees
-
35+
